{{Rsnum
|rsid=995834
|Chromosome=19
|position=28375689
|Orientation=plus
|GMAF=0.455
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 52.2 | 38.1 | 9.7
| HCB | 26.3 | 43.8 | 29.9
| JPT | 23.9 | 56.6 | 19.5
| YRI | 12.2 | 35.4 | 52.4
| ASW | 8.8 | 43.9 | 47.4
| CHB | 26.3 | 43.8 | 29.9
| CHD | 24.8 | 56.0 | 19.3
| GIH | 40.6 | 47.5 | 11.9
| LWK | 6.4 | 37.3 | 56.4
| MEX | 36.2 | 44.8 | 19.0
| MKK | 16.0 | 51.3 | 32.7
| TSI | 52.9 | 38.2 | 8.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=1E-6
  |OR=1.87
  |ORtxt=[1.364-2.566]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}